Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -7.00M
March 31, 2026 -8.00M
December 31, 2025 -7.50M
September 30, 2025 13.30M
June 30, 2025 -7.50M
March 31, 2025 16.10M
December 31, 2024 3.50M
September 30, 2024 -8.10M
June 30, 2024 265.40M
Date Value
March 31, 2024 -9.20M
December 31, 2023 -9.00M
September 30, 2023 2.70M
June 30, 2023 -9.30M
March 31, 2023 -16.20M
December 31, 2022 -18.40M
September 30, 2022 -16.90M
June 30, 2022 -7.60M
March 31, 2022 -11.10M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Charles River Laboratories International, Inc. 28.10M
IQVIA Holdings, Inc. -381.00M
Medpace Holdings, Inc. -23.88M
Champions Oncology, Inc. -0.055M
Avantor, Inc. -37.30M